［4］HYUN-CHUL K,EUNJOO K,SANG W J.et gemini polymeric micelles as controlled drug carriers[J].Macromolecular Research,2015,23:196-204.

［5］ZERRIN S,NILUEFER Y,TAMER and characterization of polymeric micelles as drug carrier system[J].Ankara Universitesi Eczacilik Fakultesi Dergisi,2003,32:125-142．

［6］VASAPOLLO G,SOLE R D,MERGOLA L,et al.Mele molecularly imprinted polymers:present and future prospective[J].,2011,12:5908-5945．

［7］VLATAKIS G,ANDERSSON L I,MüLLER R,et al.Drug assay using antibody mimics made by molecular imprinting[J].Nature,1993,361:645-647．

［8］SHIYANG D,CHUNDI applications in anticancer drug preparations[J].Shandong Huagong,2016,45:42-44．

［9］NARAHARI P,SURENDRAN V,KUPPAM L,et approach to develop and validate RP-HPLC method for estimation of erlotinib hydrochloride in nanostructured lipid carriers[J].Current Pharmaceutical Analysis,2020,16:210-219．

［10］HONGMENG Z,TINGTING M,WEI G,et and cell penetrating peptide modification effects on penetration behavior of nanostructured lipid carriers using multicellular tumor spheroids[J].Journal of Chinese Pharmaceutical Sciences,2015,24:666-672.

［11］WANG X H,LIU W Y ,ZHANG on the connection between fullerene derivatives and anticancer drugs[J].Huaxue Shiji,2018,40:103-108.

［12］CHEN L,WANG W,SU,B.et al.A light-responsive release platform by controlling the wetting behavior of hydrophobic surface[J].ACS Nano.,2014(8):351-352.

［13］CHEN Y Y,ZHAO Y B,SUN L,et porous silica carrier with gold nanoparticles for chemophotothermal combination therapy[J].Journal of Sol-Gel Science and Technology,2020,93:332-340.

文章来源：《中国中医药现代远程教育》 网址: http://www.zgzyyxdycjy.cn/qikandaodu/2021/0514/1615.html